Analysis of differences between clinical indicators of SARS and SARS-CoV-2: a preliminary study

Author:

gao bingrui1,chen haiyan1,han xiaobo2,xie lixin2,guo yinghua2

Affiliation:

1. Hainan Hospital of PLA General Hospital

2. Chinese PLA General Hospital

Abstract

Abstract Objective To investigate the difference in clinical indexes between SARS and SARS-CoV-2 and explore immune mechanisms. Methods We recorded age, sex, clinical symptoms, immunoglobulin index, arterial blood gas analysis, and other indicators of SARS patients hospitalized at the Eighth Medical Center of the People’s Liberation Army. From June 2022 to April 2023, we recorded data from patients with SARS-CoV-2 hospitalized at the Tropical Medicine Department of Hainan Hospital of the PLA General Hospital. Results There were 116 patients with SARS pneumonia and 114 with SARS-CoV-2 pneumonia. The ratio of males to females was 64/52, with an average age of 35.36 ± 15.19 years. The ratio of males to females in the SARS-CoV-2 group was 69/45, with an average age of 66.89 ± 15.00 years. There were no significant differences in PCO2, peripheral blood white blood cell count, platelet count, neutrophil ratio, serotonin ratio, blood pressure, serum creatinine, urea nitrogen, C-reactive protein, immunoglobulin IgA, and IgG indexes in blood gas analysis. There were significant differences in heart rate, blood gas analysis partial pressure, lymphocyte percentage, immunoglobulin IgM, and myocardial injury markers. Conclusions Young and middle-aged patients with SARS pneumonia were more common, while elderly patients with SARS-CoV-2 were more common. There were differences in clinical indicators between patients infected with the two viruses, and there may be differences in virulence and interaction mechanisms.

Publisher

Research Square Platform LLC

Reference16 articles.

1. Coronavirus vaccine development: from SARS and MERS to COVID-19;Li Y-D;J Biomed Sci,2020

2. Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines;Fernandes Q;Ann Med,2022

3. Long COVID: major findings, mechanisms and recommendations;Davis HE;Nat Rev Microbiol,2023

4. Characteristics of SARS-CoV-2 and COVID-19;Hu B;Nat Rev Microbiol,2020

5. Age-specific mortality and immunity patterns of SARS-CoV-2;O’Driscoll M;Nature,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3